APO Research
Talk to an analyst

APO RESEARCH · REPORT

Desloratadine Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Desloratadine Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025191 pages

Choose your research edition.

Industry ResearchDesloratadine Tablets Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Desloratadine Tablets Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Desloratadine Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Desloratadine Tablets Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Desloratadine Tablets Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Desloratadine Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Desloratadine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Desloratadine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Desloratadine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Desloratadine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Desloratadine Tablets include Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical, Yangtze River Pharmaceutical Group, Shenzhen Salubris Pharmaceuticals, Guangdong Jiuming pharmaceutical, Yingtai Pharma, Poly Pharm, Sinopharm Group Pharmaceuticals, FangYuan Pharmaceutical and Torrent Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Desloratadine Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Desloratadine Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Desloratadine Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Desloratadine Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Desloratadine Tablets Segment by Company

Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical

Yangtze River Pharmaceutical Group

Shenzhen Salubris Pharmaceuticals

Guangdong Jiuming pharmaceutical

Yingtai Pharma

Poly Pharm

Sinopharm Group Pharmaceuticals

FangYuan Pharmaceutical

Torrent Pharmaceuticals

Teva Pharmaceutical Industries

Sun Pharmaceutical Industries

Sandoz International GmbH

Perrigo Company plc

Organon Pharma

Mylan

Glenmark Pharmaceuticals

Dr. Reddy's Laboratories

Apotex

Desloratadine Tablets Segment by Type

Ordinary Tablets

Dispersible Tablets

Other

Desloratadine Tablets Segment by Application

Specialist Medical Centre

Hospital and Clinic

Retail Pharmacies

Other

Desloratadine Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Desloratadine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Desloratadine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Desloratadine Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Desloratadine Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Desloratadine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Desloratadine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Desloratadine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Desloratadine Tablets Industry Trends Table 2. Desloratadine Tablets Industry Drivers Table 3. Desloratadine Tablets Industry Opportunities and Challenges Table 4. Desloratadine Tablets Industry Restraints Table 5. Global Desloratadine Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Desloratadine Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Desloratadine Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Desloratadine Tablets Sales Market Share by Manufacturers Table 9. Global Desloratadine Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Desloratadine Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Desloratadine Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Desloratadine Tablets Manufacturers, Product Type & Application Table 13. Global Desloratadine Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Desloratadine Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Ordinary Tablets Table 17. Major Manufacturers of Dispersible Tablets Table 18. Major Manufacturers of Other Table 19. Global Desloratadine Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Desloratadine Tablets Sales by Type (2021-2026) & (K Units) Table 21. Global Desloratadine Tablets Sales by Type (2027-2032) & (K Units) Table 22. Global Desloratadine Tablets Sales Market Share by Type (2021-2026) Table 23. Global Desloratadine Tablets Sales Market Share by Type (2027-2032) Table 24. Global Desloratadine Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Desloratadine Tablets Revenue by Type (2021-2026) & (K Units) Table 26. Global Desloratadine Tablets Revenue by Type (2027-2032) & (K Units) Table 27. Global Desloratadine Tablets Revenue Market Share by Type (2021-2026) Table 28. Global Desloratadine Tablets Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Specialist Medical Centre Table 30. Major Manufacturers of Hospital and Clinic Table 31. Major Manufacturers of Retail Pharmacies Table 32. Major Manufacturers of Other Table 33. Global Desloratadine Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Desloratadine Tablets Sales by Application (2021-2026) & (K Units) Table 35. Global Desloratadine Tablets Sales by Application (2027-2032) & (K Units) Table 36. Global Desloratadine Tablets Sales Market Share by Application (2021-2026) Table 37. Global Desloratadine Tablets Sales Market Share by Application (2027-2032) Table 38. Global Desloratadine Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Desloratadine Tablets Revenue by Application (2021-2026) & (K Units) Table 40. Global Desloratadine Tablets Revenue by Application (2027-2032) & (K Units) Table 41. Global Desloratadine Tablets Revenue Market Share by Application (2021-2026) Table 42. Global Desloratadine Tablets Revenue Market Share by Application (2027-2032) Table 43. Global Desloratadine Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Desloratadine Tablets Sales by Region (2021-2026) & (K Units) Table 45. Global Desloratadine Tablets Sales Market Share by Region (2021-2026) Table 46. Global Desloratadine Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Desloratadine Tablets Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Desloratadine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Desloratadine Tablets Sales by Country (2021-2026) & (K Units) Table 50. North America Desloratadine Tablets Sales by Country (2027-2032) & (K Units) Table 51. Europe Desloratadine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Desloratadine Tablets Sales by Country (2021-2026) & (K Units) Table 53. Europe Desloratadine Tablets Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Desloratadine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Desloratadine Tablets Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Desloratadine Tablets Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Desloratadine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Desloratadine Tablets Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Desloratadine Tablets Sales by Country (2027-2032) & (K Units) Table 60. Global Desloratadine Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Desloratadine Tablets Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Desloratadine Tablets Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Desloratadine Tablets Revenue Market Share by Region (2021-2026) Table 64. Global Desloratadine Tablets Revenue Market Share by Region (2027-2032) Table 65. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Company Information Table 66. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Business Overview Table 67. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Desloratadine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Desloratadine Tablets Product Portfolio Table 69. Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Recent Development Table 70. Yangtze River Pharmaceutical Group Company Information Table 71. Yangtze River Pharmaceutical Group Business Overview Table 72. Yangtze River Pharmaceutical Group Desloratadine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Yangtze River Pharmaceutical Group Desloratadine Tablets Product Portfolio Table 74. Yangtze River Pharmaceutical Group Recent Development Table 75. Shenzhen Salubris Pharmaceuticals Company Information Table 76. Shenzhen Salubris Pharmaceuticals Business Overview Table 77. Shenzhen Salubris Pharmaceuticals Desloratadine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Shenzhen Salubris Pharmaceuticals Desloratadine Tablets Product Portfolio Table 79. Shenzhen Salubris Pharmaceuticals Recent Development Table 80. Guangdong Jiuming pharmaceutical Company Information Table 81. Guangdong Jiuming pharmaceutical Business Overview Table 82. Guangdong Jiuming pharmaceutical Desloratadine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Guangdong Jiuming pharmaceutical Desloratadine Tablets Product Portfolio Table 84. Guangdong Jiuming pharmaceutical Recent Development Table 85. Yingtai Pharma Company Information Table 86. Yingtai Pharma Business Overview Table 87. Yingtai Pharma Desloratadine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Yingtai Pharma Desloratadine Tablets Product Portfolio Table 89. Yingtai Pharma Recent Development Table 90. Poly Pharm Company Information Table 91. Poly Pharm Business Overview Table 92. Poly Pharm Desloratadine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Poly Pharm Desloratadine Tablets Product Portfolio Table 94. Poly Pharm Recent Development Table 95. Sinopharm Group Pharmaceuticals Company Information Table 96. Sinopharm Group Pharmaceuticals Business Overview Table 97. Sinopharm Group Pharmaceuticals Desloratadine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Sinopharm Group Pharmaceuticals Desloratadine Tablets Product Portfolio Table 99. Sinopharm Group Pharmaceuticals Recent Development Table 100. FangYuan Pharmaceutical Company Information Table 101. FangYuan Pharmaceutical Business Overview Table 102. FangYuan Pharmaceutical Desloratadine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. FangYuan Pharmaceutical Desloratadine Tablets Product Portfolio Table 104. FangYuan Pharmaceutical Recent Development Table 105. Torrent Pharmaceuticals Company Information Table 106. Torrent Pharmaceuticals Business Overview Table 107. Torrent Pharmaceuticals Desloratadine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Torrent Pharmaceuticals Desloratadine Tablets Product Portfolio Table 109. Torrent Pharmaceuticals Recent Development Table 110. Teva Pharmaceutical Industries Company Information Table 111. Teva Pharmaceutical Industries Business Overview Table 112. Teva Pharmaceutical Industries Desloratadine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Teva Pharmaceutical Industries Desloratadine Tablets Product Portfolio Table 114. Teva Pharmaceutical Industries Recent Development Table 115. Sun Pharmaceutical Industries Company Information Table 116. Sun Pharmaceutical Industries Business Overview Table 117. Sun Pharmaceutical Industries Desloratadine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Sun Pharmaceutical Industries Desloratadine Tablets Product Portfolio Table 119. Sun Pharmaceutical Industries Recent Development Table 120. Sandoz International GmbH Company Information Table 121. Sandoz International GmbH Business Overview Table 122. Sandoz International GmbH Desloratadine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Sandoz International GmbH Desloratadine Tablets Product Portfolio Table 124. Sandoz International GmbH Recent Development Table 125. Perrigo Company plc Company Information Table 126. Perrigo Company plc Business Overview Table 127. Perrigo Company plc Desloratadine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Perrigo Company plc Desloratadine Tablets Product Portfolio Table 129. Perrigo Company plc Recent Development Table 130. Organon Pharma Company Information Table 131. Organon Pharma Business Overview Table 132. Organon Pharma Desloratadine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Organon Pharma Desloratadine Tablets Product Portfolio Table 134. Organon Pharma Recent Development Table 135. Mylan Company Information Table 136. Mylan Business Overview Table 137. Mylan Desloratadine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Mylan Desloratadine Tablets Product Portfolio Table 139. Mylan Recent Development Table 140. Glenmark Pharmaceuticals Company Information Table 141. Glenmark Pharmaceuticals Business Overview Table 142. Glenmark Pharmaceuticals Desloratadine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Glenmark Pharmaceuticals Desloratadine Tablets Product Portfolio Table 144. Glenmark Pharmaceuticals Recent Development Table 145. Dr. Reddy's Laboratories Company Information Table 146. Dr. Reddy's Laboratories Business Overview Table 147. Dr. Reddy's Laboratories Desloratadine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Dr. Reddy's Laboratories Desloratadine Tablets Product Portfolio Table 149. Dr. Reddy's Laboratories Recent Development Table 150. Apotex Company Information Table 151. Apotex Business Overview Table 152. Apotex Desloratadine Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Apotex Desloratadine Tablets Product Portfolio Table 154. Apotex Recent Development Table 155. Key Raw Materials Table 156. Raw Materials Key Suppliers Table 157. Desloratadine Tablets Distributors List Table 158. Desloratadine Tablets Customers List Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Desloratadine Tablets Product Image Figure 2. Global Desloratadine Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Desloratadine Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Desloratadine Tablets Sales (2021-2032) & (K Units) Figure 5. Global Desloratadine Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Desloratadine Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Ordinary Tablets Image Figure 9. Dispersible Tablets Image Figure 10. Other Image Figure 11. Global Desloratadine Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Desloratadine Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Desloratadine Tablets Sales Market Share by Type (2021-2032) Figure 14. Global Desloratadine Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Desloratadine Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Desloratadine Tablets Revenue Market Share by Type (2021-2032) Figure 17. Specialist Medical Centre Image Figure 18. Hospital and Clinic Image Figure 19. Retail Pharmacies Image Figure 20. Other Image Figure 21. Global Desloratadine Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Desloratadine Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Desloratadine Tablets Sales Market Share by Application (2021-2032) Figure 24. Global Desloratadine Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Desloratadine Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Desloratadine Tablets Revenue Market Share by Application (2021-2032) Figure 27. North America Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Desloratadine Tablets Sales Market Share by Country (2021-2032) Figure 29. U.S. Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Desloratadine Tablets Sales Market Share by Country (2021-2032) Figure 34. Germany Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Desloratadine Tablets Sales Market Share by Country (2021-2032) Figure 41. China Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Desloratadine Tablets Sales Market Share by Country (2021-2032) Figure 49. Brazil Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Desloratadine Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Desloratadine Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Desloratadine Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Desloratadine Tablets Revenue (2021-2032) & (US$ Million) Figure 60. North America Desloratadine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Desloratadine Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Europe Desloratadine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Desloratadine Tablets Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Desloratadine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Desloratadine Tablets Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Desloratadine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Desloratadine Tablets Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Desloratadine Tablets Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Ordinary Tablets
  • Dispersible Tablets
  • Other
Applications
  • Specialist Medical Centre
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical
  • Yangtze River Pharmaceutical Group
  • Shenzhen Salubris Pharmaceuticals
  • Guangdong Jiuming pharmaceutical
  • Yingtai Pharma
  • Poly Pharm
  • Sinopharm Group Pharmaceuticals
  • FangYuan Pharmaceutical
  • Torrent Pharmaceuticals
  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Sandoz International GmbH
  • Perrigo Company plc
  • Organon Pharma
  • Mylan
  • Glenmark Pharmaceuticals
  • Dr. Reddy's Laboratories
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Desloratadine Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Desloratadine Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Desloratadine Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Desloratadine Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Desloratadine Tablets Market Dynamics
  1. 2.1 Desloratadine Tablets Industry Trends
  2. 2.2 Desloratadine Tablets Industry Drivers
  3. 2.3 Desloratadine Tablets Industry Opportunities and Challenges
  4. 2.4 Desloratadine Tablets Industry Restraints
3 Desloratadine Tablets Market by Manufacturers
  1. 3.1 Global Desloratadine Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Desloratadine Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Desloratadine Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Desloratadine Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Desloratadine Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Desloratadine Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Desloratadine Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Desloratadine Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Desloratadine Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Desloratadine Tablets Tier 1, Tier 2, and Tier 3
4 Desloratadine Tablets Market by Type
  1. 4.1 Desloratadine Tablets Type Introduction
  2. 4.1.1 Ordinary Tablets
  3. 4.1.2 Dispersible Tablets
  4. 4.1.3 Other
  5. 4.2 Global Desloratadine Tablets Sales by Type
  6. 4.2.1 Global Desloratadine Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Desloratadine Tablets Sales by Type (2021-2032)
  8. 4.2.3 Global Desloratadine Tablets Sales Market Share by Type (2021-2032)
  9. 4.3 Global Desloratadine Tablets Revenue by Type
  10. 4.3.1 Global Desloratadine Tablets Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Desloratadine Tablets Revenue by Type (2021-2032)
  12. 4.3.3 Global Desloratadine Tablets Revenue Market Share by Type (2021-2032)
5 Desloratadine Tablets Market by Application
  1. 5.1 Desloratadine Tablets Application Introduction
  2. 5.1.1 Specialist Medical Centre
  3. 5.1.2 Hospital and Clinic
  4. 5.1.3 Retail Pharmacies
  5. 5.1.4 Other
  6. 5.2 Global Desloratadine Tablets Sales by Application
  7. 5.2.1 Global Desloratadine Tablets Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Desloratadine Tablets Sales by Application (2021-2032)
  9. 5.2.3 Global Desloratadine Tablets Sales Market Share by Application (2021-2032)
  10. 5.3 Global Desloratadine Tablets Revenue by Application
  11. 5.3.1 Global Desloratadine Tablets Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Desloratadine Tablets Revenue by Application (2021-2032)
  13. 5.3.3 Global Desloratadine Tablets Revenue Market Share by Application (2021-2032)
6 Global Desloratadine Tablets Sales by Region
  1. 6.1 Global Desloratadine Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Desloratadine Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Desloratadine Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Desloratadine Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Desloratadine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Desloratadine Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Desloratadine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Desloratadine Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Desloratadine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Desloratadine Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Desloratadine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Desloratadine Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Desloratadine Tablets Revenue by Region
  1. 7.1 Global Desloratadine Tablets Revenue by Region
  2. 7.1.1 Global Desloratadine Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Desloratadine Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Desloratadine Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Desloratadine Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Desloratadine Tablets Revenue (2021-2032)
  8. 7.2.2 North America Desloratadine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Desloratadine Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Desloratadine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Desloratadine Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Desloratadine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Desloratadine Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Desloratadine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical
  2. 8.1.1 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Company Information
  3. 8.1.2 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Desloratadine Tablets Product Portfolio
  6. 8.1.5 Zhejiang China Resources Sanjiu Zhongyi Pharmaceutical Recent Developments
  7. 8.2 Yangtze River Pharmaceutical Group
  8. 8.2.1 Yangtze River Pharmaceutical Group Company Information
  9. 8.2.2 Yangtze River Pharmaceutical Group Business Overview
  10. 8.2.3 Yangtze River Pharmaceutical Group Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yangtze River Pharmaceutical Group Desloratadine Tablets Product Portfolio
  12. 8.2.5 Yangtze River Pharmaceutical Group Recent Developments
  13. 8.3 Shenzhen Salubris Pharmaceuticals
  14. 8.3.1 Shenzhen Salubris Pharmaceuticals Company Information
  15. 8.3.2 Shenzhen Salubris Pharmaceuticals Business Overview
  16. 8.3.3 Shenzhen Salubris Pharmaceuticals Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shenzhen Salubris Pharmaceuticals Desloratadine Tablets Product Portfolio
  18. 8.3.5 Shenzhen Salubris Pharmaceuticals Recent Developments
  19. 8.4 Guangdong Jiuming pharmaceutical
  20. 8.4.1 Guangdong Jiuming pharmaceutical Company Information
  21. 8.4.2 Guangdong Jiuming pharmaceutical Business Overview
  22. 8.4.3 Guangdong Jiuming pharmaceutical Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Guangdong Jiuming pharmaceutical Desloratadine Tablets Product Portfolio
  24. 8.4.5 Guangdong Jiuming pharmaceutical Recent Developments
  25. 8.5 Yingtai Pharma
  26. 8.5.1 Yingtai Pharma Company Information
  27. 8.5.2 Yingtai Pharma Business Overview
  28. 8.5.3 Yingtai Pharma Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Yingtai Pharma Desloratadine Tablets Product Portfolio
  30. 8.5.5 Yingtai Pharma Recent Developments
  31. 8.6 Poly Pharm
  32. 8.6.1 Poly Pharm Company Information
  33. 8.6.2 Poly Pharm Business Overview
  34. 8.6.3 Poly Pharm Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Poly Pharm Desloratadine Tablets Product Portfolio
  36. 8.6.5 Poly Pharm Recent Developments
  37. 8.7 Sinopharm Group Pharmaceuticals
  38. 8.7.1 Sinopharm Group Pharmaceuticals Company Information
  39. 8.7.2 Sinopharm Group Pharmaceuticals Business Overview
  40. 8.7.3 Sinopharm Group Pharmaceuticals Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sinopharm Group Pharmaceuticals Desloratadine Tablets Product Portfolio
  42. 8.7.5 Sinopharm Group Pharmaceuticals Recent Developments
  43. 8.8 FangYuan Pharmaceutical
  44. 8.8.1 FangYuan Pharmaceutical Company Information
  45. 8.8.2 FangYuan Pharmaceutical Business Overview
  46. 8.8.3 FangYuan Pharmaceutical Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 FangYuan Pharmaceutical Desloratadine Tablets Product Portfolio
  48. 8.8.5 FangYuan Pharmaceutical Recent Developments
  49. 8.9 Torrent Pharmaceuticals
  50. 8.9.1 Torrent Pharmaceuticals Company Information
  51. 8.9.2 Torrent Pharmaceuticals Business Overview
  52. 8.9.3 Torrent Pharmaceuticals Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Torrent Pharmaceuticals Desloratadine Tablets Product Portfolio
  54. 8.9.5 Torrent Pharmaceuticals Recent Developments
  55. 8.10 Teva Pharmaceutical Industries
  56. 8.10.1 Teva Pharmaceutical Industries Company Information
  57. 8.10.2 Teva Pharmaceutical Industries Business Overview
  58. 8.10.3 Teva Pharmaceutical Industries Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Teva Pharmaceutical Industries Desloratadine Tablets Product Portfolio
  60. 8.10.5 Teva Pharmaceutical Industries Recent Developments
  61. 8.11 Sun Pharmaceutical Industries
  62. 8.11.1 Sun Pharmaceutical Industries Company Information
  63. 8.11.2 Sun Pharmaceutical Industries Business Overview
  64. 8.11.3 Sun Pharmaceutical Industries Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sun Pharmaceutical Industries Desloratadine Tablets Product Portfolio
  66. 8.11.5 Sun Pharmaceutical Industries Recent Developments
  67. 8.12 Sandoz International GmbH
  68. 8.12.1 Sandoz International GmbH Company Information
  69. 8.12.2 Sandoz International GmbH Business Overview
  70. 8.12.3 Sandoz International GmbH Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sandoz International GmbH Desloratadine Tablets Product Portfolio
  72. 8.12.5 Sandoz International GmbH Recent Developments
  73. 8.13 Perrigo Company plc
  74. 8.13.1 Perrigo Company plc Company Information
  75. 8.13.2 Perrigo Company plc Business Overview
  76. 8.13.3 Perrigo Company plc Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Perrigo Company plc Desloratadine Tablets Product Portfolio
  78. 8.13.5 Perrigo Company plc Recent Developments
  79. 8.14 Organon Pharma
  80. 8.14.1 Organon Pharma Company Information
  81. 8.14.2 Organon Pharma Business Overview
  82. 8.14.3 Organon Pharma Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Organon Pharma Desloratadine Tablets Product Portfolio
  84. 8.14.5 Organon Pharma Recent Developments
  85. 8.15 Mylan
  86. 8.15.1 Mylan Company Information
  87. 8.15.2 Mylan Business Overview
  88. 8.15.3 Mylan Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Mylan Desloratadine Tablets Product Portfolio
  90. 8.15.5 Mylan Recent Developments
  91. 8.16 Glenmark Pharmaceuticals
  92. 8.16.1 Glenmark Pharmaceuticals Company Information
  93. 8.16.2 Glenmark Pharmaceuticals Business Overview
  94. 8.16.3 Glenmark Pharmaceuticals Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Glenmark Pharmaceuticals Desloratadine Tablets Product Portfolio
  96. 8.16.5 Glenmark Pharmaceuticals Recent Developments
  97. 8.17 Dr. Reddy's Laboratories
  98. 8.17.1 Dr. Reddy's Laboratories Company Information
  99. 8.17.2 Dr. Reddy's Laboratories Business Overview
  100. 8.17.3 Dr. Reddy's Laboratories Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Dr. Reddy's Laboratories Desloratadine Tablets Product Portfolio
  102. 8.17.5 Dr. Reddy's Laboratories Recent Developments
  103. 8.18 Apotex
  104. 8.18.1 Apotex Company Information
  105. 8.18.2 Apotex Business Overview
  106. 8.18.3 Apotex Desloratadine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Apotex Desloratadine Tablets Product Portfolio
  108. 8.18.5 Apotex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Desloratadine Tablets Value Chain Analysis
  2. 9.1.1 Desloratadine Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Desloratadine Tablets Production Mode & Process
  6. 9.2 Desloratadine Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Desloratadine Tablets Distributors
  9. 9.2.3 Desloratadine Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst